Page 13 - Mark Rothera News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Top UK Stocks to Watch: Beazley shares jump despite pandemic-induced loss

Beazley expects to bounce back strongly this year, Syncona’s investment in Achilles could benefit as it considers an IPO, Silence Therapeutics raises funds to help capitalise on current momentum, and energy suppliers like SSE and Centrica rise as Ofgem raises its price cap.

United kingdomAkwa ibomDave fredricksonNick matherAndrew hortonMark rotheraAndrew knottMansour groupMulak energySavannah energyTop newsAchilles therapeuticsAmerican depositary sharesCity indexTop stocks to watchStocks to buy

Pubs and bus companies among the top risers

Pubs and bus companies among the top risers
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCity ofOrkney islandsLaura ashleyThomas adamsAndrew hortonNigel burtonJohn quinlanSam asanteSarah deesMartin gouldstoneMark rotheraNed staceyBoris johnsonUniversity of california

Proactive news headlines: Iconic Labs PLC, Silence Therapeutics PLC, Chaarat Gold Holdings Ltd, Tiziana Life Sciences PLC

Proactive news headlines: Iconic Labs PLC, Silence Therapeutics PLC, Chaarat Gold Holdings Ltd, Tiziana Life Sciences PLC
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

United statesSouth africaIron ridgeEastern capeThomas adamsArvind guptaNigel burtonSarah deesPeter seckerMartin gouldstoneMark rotheraNed staceyUniversity of californiaProactive researchBacanora lithiumLabro investments ltd

Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines Silence Therapeutics appoints Craig Tooman as CFO

By BFN News | 09:23 AM | Wednesday 06 January, 2021 Silence Therapeutics, a biotechnology company that develops gene therapeutic technology based on RNA interference, has announced Craig Tooman as its new chief financial officer and Michael Davidson as a non-executive director of the board. Tooman has also become a member of the executive leadership team, effective immediately. His career in the biopharmaceutical industry spans more than 30 years, including 15 years of experience as a public company CFO. Most recently, he was CFO and chief operating officer at Vyome Therapeutics, and prior to this was CFO and then CEO of Aratana Therapeutics where he successfully negotiated a merger with Elanco.

United statesUniversity of chicagoCraig toomanMichael davidsonMark rotheraProduct developmentChicago centerClinical researchSilence therapeuticsVyome therapeuticsAratana therapeuticsLipid clinicNew amsterdamPharmaceutical product developmentஒன்றுபட்டது மாநிலங்களில்பல்கலைக்கழகம் ஆஃப் சிகாகோ